Alnylam Pharmaceuticals
ALNY
#510
Rank
A$70.41 B
Marketcap
A$532.96
Share price
-0.17%
Change (1 day)
24.61%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company